Literature DB >> 16708491

Shutting down Alzheimer's.

Michael S Wolfe1.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16708491     DOI: 10.1038/scientificamerican0506-72

Source DB:  PubMed          Journal:  Sci Am        ISSN: 0036-8733            Impact factor:   2.142


× No keyword cloud information.
  7 in total

Review 1.  Developing novel immunogens for a safe and effective Alzheimer's disease vaccine.

Authors:  Cynthia A Lemere
Journal:  Prog Brain Res       Date:  2009       Impact factor: 2.453

Review 2.  Apolipoprotein E as a Therapeutic Target in Alzheimer's Disease: A Review of Basic Research and Clinical Evidence.

Authors:  Yu Yamazaki; Meghan M Painter; Guojun Bu; Takahisa Kanekiyo
Journal:  CNS Drugs       Date:  2016-09       Impact factor: 5.749

Review 3.  When loss is gain: reduced presenilin proteolytic function leads to increased Abeta42/Abeta40. Talking Point on the role of presenilin mutations in Alzheimer disease.

Authors:  Michael S Wolfe
Journal:  EMBO Rep       Date:  2007-02       Impact factor: 8.807

4.  Selective translational control of the Alzheimer amyloid precursor protein transcript by iron regulatory protein-1.

Authors:  Hyun-Hee Cho; Catherine M Cahill; Charles R Vanderburg; Clemens R Scherzer; Bin Wang; Xudong Huang; Jack T Rogers
Journal:  J Biol Chem       Date:  2010-06-17       Impact factor: 5.157

Review 5.  Can Alzheimer disease be prevented by amyloid-beta immunotherapy?

Authors:  Cynthia A Lemere; Eliezer Masliah
Journal:  Nat Rev Neurol       Date:  2010-02       Impact factor: 42.937

Review 6.  Alternative pathways for production of beta-amyloid peptides of Alzheimer's disease.

Authors:  Vivian Hook; Israel Schechter; Hans-Ulrich Demuth; Gregory Hook
Journal:  Biol Chem       Date:  2008-08       Impact factor: 3.915

7.  A beneficial role for IL-1 beta in Alzheimer disease?

Authors:  Cynthia A Lemere
Journal:  J Clin Invest       Date:  2007-06       Impact factor: 14.808

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.